Literature DB >> 19056308

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.

Radu Constantinescu1, Megan Romer, David Oakes, Lars Rosengren, Karl Kieburtz.   

Abstract

BACKGROUND: Neurofilaments are major structural elements of neuronal cells. The light subunit of neurofilament triplet protein (NFL) has been shown to be increased in several neurological diseases (e.g. vascular, infectious, neurodegenerative), indicating axonal damage.
METHODS: In this study we analyzed the NFL levels in all (N=35) available cerebrospinal fluid (CSF) samples from a clinical trial in Huntington's disease (HD) and compared them to age and gender matched controls.
RESULTS: The CSF-NFL levels were significantly higher in HD subjects compared with age and genders matched controls, and were correlated with scores on the Unified Huntington's Disease Rating Scale Total Functional Capacity assessment. The potential of CSF-NFL levels as a disease activity marker in HD needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056308     DOI: 10.1016/j.parkreldis.2008.05.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  18 in total

1.  Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.

Authors:  Edward J Wild; Roberto Boggio; Douglas Langbehn; Nicola Robertson; Salman Haider; James R C Miller; Henrik Zetterberg; Blair R Leavitt; Rainer Kuhn; Sarah J Tabrizi; Douglas Macdonald; Andreas Weiss
Journal:  J Clin Invest       Date:  2015-04-06       Impact factor: 14.808

Review 2.  Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies.

Authors:  Deepa Dash; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

3.  Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.

Authors:  Nicholas S Caron; Raul Banos; Christopher Yanick; Amirah E Aly; Lauren M Byrne; Ethan D Smith; Yuanyun Xie; Stephen E P Smith; Nalini Potluri; Hailey Findlay Black; Lorenzo Casal; Seunghyun Ko; Daphne Cheung; Hyeongju Kim; Ihn Sik Seong; Edward J Wild; Ji-Joon Song; Michael R Hayden; Amber L Southwell
Journal:  J Neurosci       Date:  2020-12-11       Impact factor: 6.167

Review 4.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

5.  Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.

Authors:  Filipe B Rodrigues; Lauren M Byrne; Rosanna Tortelli; Eileanoir B Johnson; Peter A Wijeratne; Marzena Arridge; Enrico De Vita; Naghmeh Ghazaleh; Richard Houghton; Hannah Furby; Daniel C Alexander; Sarah J Tabrizi; Scott Schobel; Rachael I Scahill; Amanda Heslegrave; Henrik Zetterberg; Edward J Wild
Journal:  Sci Transl Med       Date:  2020-12-16       Impact factor: 17.956

6.  The cerebrospinal fluid proteome in HIV infection: change associated with disease severity.

Authors:  Thomas E Angel; Jon M Jacobs; Serena S Spudich; Marina A Gritsenko; Dietmar Fuchs; Teri Liegler; Henrik Zetterberg; David G Camp; Richard W Price; Richard D Smith
Journal:  Clin Proteomics       Date:  2012-03-20       Impact factor: 3.988

7.  Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease.

Authors:  Yen-Chu Huang; Yih-Ru Wu; Mu-Yun Tseng; Yi-Chun Chen; Sen-Yung Hsieh; Chiung-Mei Chen
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

8.  Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.

Authors:  Tua Vinther-Jensen; Lars Börnsen; Esben Budtz-Jørgensen; Cecilie Ammitzbøll; Ida U Larsen; Lena E Hjermind; Finn Sellebjerg; Jørgen E Nielsen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-09-28

9.  Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.

Authors:  Lauren M Byrne; Filipe B Rodrigues; Kaj Blennow; Alexandra Durr; Blair R Leavitt; Raymund A C Roos; Rachael I Scahill; Sarah J Tabrizi; Henrik Zetterberg; Douglas Langbehn; Edward J Wild
Journal:  Lancet Neurol       Date:  2017-06-07       Impact factor: 44.182

Review 10.  Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.

Authors:  Sarah J Tabrizi; Michael D Flower; Christopher A Ross; Edward J Wild
Journal:  Nat Rev Neurol       Date:  2020-08-14       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.